Element is little more than a decade old, but can trace its origins back to 1827. With roots based in industrial testing and measurement  in the Victorian era, Element businesses have been involved in materials and product testing that gave the world the Model T ford, put Concorde into the skies and has helped keep Venice afloat. 

Element was formed in 2010, after a management buy-out of the testing division of the Netherlands-based Stork Engineering Group, backed by 3i Group plc. Starting with 860 people in 27 laboratories, the Group has grown dramatically in the last ten years, as many organisations have moved their testing requirements to specialist providers.

Gad Consulting Services (GCS) has been providing expert toxicology services to pharmaceutical and medical device companies for over 30 years. We have experience with drugs, devices, and combination products in numerous therapeutic areas, throughout all stages of development and for those already on the market. GCS is proud to offer toxicology and biocompatibility support tailored to meet the specific needs of our clients. Consulting services include:

· Regulatory strategy development; design of full non-clinical and biocompatibility testing programs;

· Medical device gap assessments, biological evaluations, change assessments, bioequivalence determinations

· Study placement and monitoring, report review and preparation, lab audits;

· IND writing, preparation, and filing

· Interaction with regulators, including response to deficiencies without previous project involvement;

Our team has extensive experience in toxicological risk assessment (TRA) methods including the estimation of acceptable exposure limits, and the application of (Q)SAR methodology. Gad Consulting is well-known for the quality and consistent regulatory acceptance of our reports on:

· TRA of medical device extractables, leachables, and volatile organic substances (ISO 10993, ISO 18562)

· TRA of drug packaging and manufacturing equipment extractables and leachables (ICH Q3)

· Qualification of impurities, degradants, residual solvents, and excipients (ICH Q3)

· Mutagenicity evaluation and calculation of compound specific limits, including nitrosamines (ICH M7, (Q)SAR)

Why Choose Nelson Laboratories

Every year, hundreds of medical device, pharmaceutical, and tissue companies make Nelson Labs their testing laboratory of choice. For them, the decision is easy. Nelson Labs is a clear leader in the microbiology testing industry, offering more than 800 laboratory tests and employing more than 500 scientists and staff in state-of-the-art facilities. We are known for exceptional quality and rigorous testing standards, but it’s our focus on the bigger picture that sets us apart. We look beyond test results and partner with you to achieve your long-term business goals — mitigating risk, being first to market, and succeeding with your customers.
Companies choose Nelson Laboratories for our:

• Thought leaders and approachable experts. We give you direct access to industry authorities who understand your business and add value every step of the way.
• Customer-centric culture. We take the time to understand your vision. Your goals become our goals.
• Real-time project management tools and a dedicated client portal. We provide proactive information, keeping you informed and in control.
• Metric-driven testing processes. We're our own toughest customer, holding ourselves to goals exceeding 99% for things that matter most to you, like quality, turn-around time, and testing accuracy.
• Global compliance expertise and support. We act as a trusted advisor, helping you navigate the ever-changing compliance landscape.

See how we can help you mitigate risk, be first to market, and succeed with your customers.